HealthHIV and the National Coalition for LGBTQ Health invite you to watch an archived webinar with expert faculty discussing real‑world decision making for antiretroviral therapy (ART). Through case examples, they explore common scenarios: factoring resistance into initial ART choice for treatment‑naïve patients, pre‑switch assessment for virally suppressed patients considering a regimen change, and how prior PrEP use affects subsequent ART selection. This archived webinar will equip clinicians with practical knowledge and tools to assess and manage ART resistance in today’s evolving clinical landscape.
Learning Objectives
- At the end of this activity, you will be able to:
- Describe the mechanisms of HIV resistance development.
- Apply strategies to assess and manage treatment-naïve patients.
- Confidently navigate regimen switches in patients with viral suppression.
- Review emerging therapies and future directions in ART.